Pneumocystis jirovecii can cause severe potentially life-threatening pneumonia (PCP) in kidney transplant patients. Prophylaxis of patients against PCP in this setting is usually performed during 6 months after transplantation. The aim of this study is to describe the molecular epidemiology of a cluster of PCP in renal transplant recipients in Brazil. Renal transplant patients who developed PCP between May and December 2011 had their formalin-fixed paraffin-embedded (FFPE) lung biopsy samples analysed. Pneumocystis jirovecii 23S mitochondrial large subunit of ribosomal RNA (23S mtLSU-rRNA), 26S rRNA, and dihydropteroate synthase (DHPS) genes were amplified by polymerase chain reaction (PCR), sequenced, and analysed for genetic variation. During the study period, 17 patients developed PCP (only four infections were documented within the first year after transplantation) and six (35.3%) died. Thirty FFPE samples from 11 patients, including one external control HIV-infected patient, had fungal DNA successfully extracted for further amplification and sequencing for all three genes. A total of five genotypes were identified among the 10 infected patients. Of note, four patients were infected by more than one genotype and seven patients were infected by the same genotype. DNA extracted from FFPE samples can be used for genotyping; this approach allowed us to demonstrate that multiple P. jirovecii strains were responsible for this cluster, and one genotype was found infecting seven patients. The knowledge of the causative agents of PCP may help to develop new initiatives for control and prevention of PCP among patients undergoing renal transplant and improve routine PCP prophylaxis.
Summary
Pneumocystis jirovecii can cause severe potentially life-threatening pneumonia (PCP) in kidney transplant patients. Prophylaxis of patients against PCP in this setting is usually performed during 6 months after transplantation. The aim of this study is to describe the molecular epidemiology of a cluster of PCP in renal transplant recipients in Brazil. Renal transplant patients who developed PCP between May and December 2011 had their formalin-fixed paraffin-embedded (FFPE) lung biopsy samples analysed. Pneumocystis jirovecii 23S mitochondrial large subunit of ribosomal RNA (23S mtLSU-rRNA), 26S rRNA, and dihydropteroate synthase (DHPS) genes were amplified by polymerase chain reaction (PCR), sequenced, and analysed for genetic variation. During the study period, 17 patients developed PCP (only four infections were documented within the first year after transplantation) and six (35.3%) died. Thirty FFPE samples from 11 patients, including one external control HIV-infected patient, had fungal DNA successfully extracted for further amplification and sequencing for all three genes. A total of five genotypes were identified among the 10 infected patients. Of note, four patients were infected by more than one genotype and seven patients were infected by the same genotype. DNA extracted from FFPE samples can be used for genotyping; this approach allowed us to demonstrate that multiple P. jirovecii strains were responsible for this cluster, and one genotype was found infecting seven patients. The knowledge of the causative agents of PCP may help to develop new initiatives for control and prevention of PCP among patients undergoing renal transplant and improve routine PCP prophylaxis.
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| INTRODUC TI ON
Pneumocystis jirovecii can cause severe potentially life-threatening pneumonia (PCP) in immunocompromised patients, especially those with HIV/AIDS and those who have undergone solid organ transplantation. 1, 2 Kidney transplant patients appear to be at especially high risk, primarily within the first 6 months after transplantation, with outbreaks being reported over the past 10 years from multiple transplant centres throughout the world, especially in Europe, Japan, and Australia. [3] [4] [5] [6] [7] [8] [9] [10] Of note, to date, there have been no reports of PCP outbreaks or clusters in renal transplant patients in Brazil.
PCP in transplant recipients can be associated with mortality rates up to 50%, highlighting the need for early diagnosis and timely initiation of anti-Pneumocystis therapy. 8, 11 The reason for the relatively recent increase in frequency of outbreaks is unclear; potential explanations include the introduction of specific P. jirovecii strains into the hospital environment, changes in immunosuppressive regimens, or other factors affecting patient susceptibility. 8, 11, 12 Since Pneumocystis cannot be cultured, molecular typing meth- Few Pneumocystis typing studies have been carried out using samples derived from FFPE tissues, 18 in part because it is difficult to obtain good-quality DNA from such tissues due to potential crosslinking of DNA, the presence of inhibitors, and other factors. 19 This study reports on the molecular epidemiology of a cluster of PCP cases in renal transplant patients that occurred in a single medical centre in the city of São Paulo, Brazil; most cases developed more than 6 months after transplantation, the period traditionally considered highest risk for development of PCP.
| PATIENTS AND ME THODS

| Study design, setting, and ethics
This was a crosssectional retrospective study enrolling all kidney transplant recipients admitted at a renal transplantation hospital This study was approved by the local ethics committee (protocol no. CEP 1414/09). Informed consent from patients was waived due to the retrospective character of this study.
| Casuistic
In this series, cases were included only when formalin-fixed paraffin- 
| Procedures for DNA sequencing and analysis
DNA sequencing was performed as previously described. 24 For analysis of 23S mtLSU rRNA, 26S rRNA and DHPS genes of P. jirovecii, the forward and reverse primers for the target genes analysed were used, and the Big Dye Terminator Reaction kit v3.1 (Applied Biosystems, Inc.), according to the manufacturer's instructions.
Samples were run on an automated ABI 3130 genetic analyser (Applied Biosystems, Inc.)
DNA sequence assembly and editing was performed using or haplotype diversity (Hd), and nucleotide diversity (Pi). 30 For the concatenated data (26S + mt23S), only the 30 sequences generated in this study were used (n = 11 patients), as there were no nucleotides sequences derived from well-characterised P. jirovecii for both loci (26S + mt23S) available in public databases. The genotype network file (Roehl data file) was created using DnaSP v.5.10, considering gaps. The network was generated by the median-joining method 31 using Network v4.6 software (http://www.fluxus-engineering.com/).
Genetic relationships among Pneumocystis sequences were investigated by phylogenetic analysis of concatenated 26S and mt23S using neighbour-joining, maximum likelihood, and maximum parsimony methods. Phylogenetic trees were constructed in MEGA7.
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Considering the Bayesian information criterion (BIC) and Akaike information criterion (AIC), 33 the Tamura 3-parameter model (T92 model) 34 was found to be the best evolutionary model, and the robustness of branches was assessed by bootstrap analysis of 1000 replicates.
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| RE SULTS
During the 7-month period of study, 17 patients among a total of 6196 kidney transplant recipients assisted at our institution developed PCP. During the cluster period, we found an incidence rate of 0.27 cases per 100 kidney transplants-while along the 10 yearsperiod previously to this cluster only seven cases of PCP had been diagnosed among 7063 kidney transplant recipients attending our division, representing 0.099 cases per 100 kidney transplants.
Among the 17 initially selected patients, 16 had received their organ from deceased donors, including two kidney-pancreas transplant recipients, and one from a living donor. Table 1 (Table 2) . Thus, sequences of concatenated 26S and mt23S
were aligned, which were 594 bp long, including 587 invariable sites, and seven variable parsimony-informative sites (1.17%; Table 2 ).
A phylogenetic tree was constructed using neighbour-joining (model T92) with 1000 bootstrap replications ( Figure 1A ). The 30 operational taxonomic units were distributed into five main P. jirovecii clusters (genotypes 1-5). Remarkably, different FFPE samples recovered from the same patient were often in different clusters, revealing a substantial level of coinfection (four patients, 36.3%) with at least two genotypes. When evolutionary relationships among strains were evaluated using haplotype networks, to visualise differences and diversity among P. jirovecii sequences, the five genotypes above were recognised (G1-G5, Hd = 0.69; Figure 1B ). The majority of sequences were assigned to G1 (seven out 11 patients; Figure 1C ).
The more samples per patient that were analysed, the more diversity was seen. In the patient #5, for whom seven samples were analysed, three unique genotypes were identified (G1, G3, and G5). The patient #9 (HIV-positive) presented a different genotype when compared to the renal transplant patients, belonging to a distinct group (G4) as can be observed in Figure 1A -C. A detailed analysis of the genotypes by patient and sample is provided in Table S2 .
As mentioned, the DHPS sequence analysis was not informative concerning strain variation. However, when compared to other sequences deposited in GenBank, all 30 sequences belonged to one group, which was named as G_11, with a 100% identity to the following sequences: U66282; U66279; AJ586567; JX101868; AF139132.
Although no nucleotide variability has been found among the samples from our study, the haplotype analysis revealed other seven genotypes (G_2-G_8) comprising distinct nucleotide sequences from GenBank: G_2 (U66281); G_3 (U66280); G_4 (U66278); G_5 (GU479993); G_6 (GU479992); G_7 (GU479994); G_8 (AM404075) (Figure 2 ). histopathological evaluation of the affected tissue, and identification of other potential pathologic processes. 37 It is important to highlight that bronchoscopy and lung biopsies of the present patients were requested by their medical assistants to investigate other causes of pneumonia usually documented in the late period after kidney transplantation. In addition, as mentioned before, immunofluorescence tests and PCR for PCP are not available in our institution.
| D ISCUSS I ON
The present cluster of PCP cases was caused by multiple strains, suggesting that different environmental sources of infection could be involved. It is worth mentioning that the molecular typing we used may be more sensitive in identifying intraspecies variation, in contrast to other reports where most of strains causing clusters of PCP were identical. In this scenario, Rostved et al 9 described three unique Pneumocystis genotypes shared among renal transplanted and liver transplanted patients presenting three distinct clusters of PCP, two of which overlapped temporally.
Our methodology may, however, have impacted our findings. In many cases of PCP, multiple P. jirovecii strains can be identified in one patient. 23, 36, 38 Many typing methods that rely on PCR will, however, often only identify the predominant strain unless amplified products are subcloned prior to Sanger sequencing, or next-generation sequencing is utilised. By testing multiple tissue samples from the same patient, we F I G U R E 1 Genetic diversity of Pneumocystis jirovecii pneumonia during a cluster in renal transplant recipients (RTRs). A, Phylogenetic relationships, as inferred from a neighbour-joining analysis (model T92) of the concatenated nuclear 26S and the mitochondrial 23S mtLSU sequences from 28 samples obtained from 10 RTRs and 2 samples from one (1) HIV-infected patient (pt. 9). The numbers close to the branches represent indices of support (NJ/ML/MP) based on 1000 bootstrap replications. The branches with bootstrap support higher than 80% are indicated in bold. NJ, neighbour-joining; ML, maximum likelihood; MP, maximum parsimony. B, Median-joining haplotype/ genotype network of P. jirovecii samples, covering all genotypes (G_1-G_5) found in this study. The size of the circumference is proportional to the genotype frequency in the dataset. Mutational steps are represented by white dots. C, The genotypes are colour coded, and their frequencies per patient are shown. Coinfection with at least two different P. jirovecii genotypes was found in four of the eleven patients evaluated. Further information about isolate source can be found in the Table S2 potentially were more successful in documenting genetic variability as a consequence of infection with multiple strains of P. jirovecii, especially if there is uneven distribution of the strains within the lung. As shown in the current study, the more FFPE samples we tested, the greater the level of genetic diversity we identified (eg, patient #5). 23, 36, 38 However, despite the fact that multiple genotypes were documented in four patients, by checking carefully our data, we were able to document the predominance of some genotypes infecting different patients. As an example, genotype G1 was found infecting seven out 10 patients enrolled in our casuistic, and genotype G3 was found in four patients.
MLST-based genotyping is the gold standard for characterisation of strains (especially because Pneumocystis spp. are not able to grow in culture media), providing an excellent discriminatory power. [39] [40] [41] [42] One important clinical observation in this study was the late occurrence of PCP in 76% of patients (14/17), a time during which the risk of PCP has previously been considered low. At the time we documented the cluster of PCP, prophylaxis with trimethoprim/sulfamethoxazole (TMP/SMX) was usually prescribed for only 6 months after transplantation. It means that all patients with PCP
were not under TMP/SMX prophylaxis at the time they developed infection.
Several other recent studies have reported an increase in the incidence of PCP more than 1 year after transplantation, suggesting that the risk period for PCP in renal transplant patients may need to be re-assessed, and the time for antifungal prophylaxis in this group of patients should be reevaluated, especially for high-risk patients.
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Our hospital is a reference transplant centre in Brazil and performs organ transplantation for patients from different states and regions.
Although most of our patients were from the state of São Paulo, where our institution is located, there were many patients in the PCP cluster period who came from neighbouring states. As these patients were already sick at the time they came to the hospital, it is more likely that their infection was community-acquired. This scenario could help us to explain the four different genotypes we found infecting our patients.
Otherwise, we may not exclude the possibility that some of them could have been colonised at any time during their medical assistance in our hospital setting, including the outpatient clinic where they collect routine laboratory exams. That possibility would explain the finding of a single genotyping (G-1) infecting seven out 10 patients of the cluster.
A limitation of the study includes problems related to molecular tool used, as well as its interpretation. Currently, Multilocus sequence typing (MLST) has become the most used method and was applied in several cluster or outbreak analyses. However, highly discriminant methods such as ITS sequencing with subcloning of the PCR products and multitarget SSCP (single-strand conformation polymorphism analysis) are still used in many others studies.
Molecular methods of Pneumocystis genotyping are under construction and they should be analysed with caution. [39] [40] [41] [42] 46 Finally, it is worth noting that crude mortality rate of patients with PCP in the current study was 35%. This finding highlights that PCP continues to be a potentially life-threatening complication of renal transplantation. It is critical to better understand the epidemiology and risk factors of patients who develop PCP more than 6 months after transplantation in order to optimise strategies for prevention of this infection in this setting of patients. 
F I G U R E 2
Comparative analysis of DHPS gene of Pneumocystis jirovecii pneumonia during a cluster in renal transplant recipients (RTRs). Median-joining haplotype/genotype network of P. jirovecii samples, covering all genotypes (G_1 to G_8) found in this study and in GenBank. The size of the circumference is proportional to the genotype frequency in the dataset. G_1: comprises all the 30 samples of the study and the following sequences deposited on GenBank: U66282; U66279; AJ586567; JX101868; AF139132. But it also (G_1) showed some minor differences compared to the following genotypes: G_2: U66281; G_3: U66280; G_4: U66278; G_5: GU479993; G_6: GU479992; G_7: GU479994; G_8: AM404075 (sequences from GenBank) 
